Skip to main content
. 2021 Oct 26;22(21):11563. doi: 10.3390/ijms222111563

Figure 1.

Figure 1

Percentage of BDCA-1+CD19 (A) and BDCA-2+CD123+ cells (B) in healthy blood donors and peripheral blood, peritoneal fluid, and among ovarian cancer infiltrating cells. The median value with the following marks indicate statistically significant differences: * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.